RLAY
Relay Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+0.10%
vs ±17.0% implied · ×0.01
shaded = implied · ▲▼ = realized
Relay Therapeutics, Inc.
18.35
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | SB Investment Advisers (uk)SB Investment Advisers (uk) | $522.1M | 11.17% | 0.00% | |
| 2 | FMRFMR | $376.3M | 8.05% | +444.19% | |
| 3 | Casdin CapitalCasdin Capital | $300.0M | 6.42% | +11.21% | |
| 4 | BlackRockBlackRockindex-like | $286.0M | 6.12% | +17.83% | |
| 5 | Perceptive AdvisorsPerceptive | $263.9M | 5.65% | +44.66% | |
| 6 | Commodore CapitalCommodore Capital | $224.5M | 4.80% | −29.41% | |
| 7 | State StreetState Streetindex-like | $189.5M | 4.05% | +62.43% | |
| 8 | Vanguard Capital ManagementVanguardindex-like | $167.7M | 3.59% | new | |
| 9 | T. Rowe Price AssociatesT. Rowe Price | $144.2M | 3.09% | +300.45% | |
| 10 | Nextech InvestNextech Invest | $126.8M | 2.71% | +22.62% | |
| 11 | Bellevue GroupBellevue | $115.7M | 2.48% | −20.64% | |
| 12 | Geode Capital ManagementGeodeindex-like | $88.4M | 1.89% | +34.64% | |
| 13 | TCG Crossover ManagementTCG Crossover | $80.0M | 1.71% | 0.00% | |
| 14 | AlliancebernsteinAlliancebernstein | $76.6M | 1.64% | +2719.67% | |
| 15 | Morgan StanleyMorgan Stanley | $72.1M | 1.54% | +168.93% | |
| 16 | SirenSiren | $68.3M | 1.46% | new | |
| 17 | Goldman Sachs GroupGoldman Sachs | $63.8M | 1.36% | +34.10% | |
| 18 | Westfield Capital ManagementWestfield | $62.6M | 1.34% | new | |
| 19 | Kynam Capital ManagementKynam | $61.7M | 1.32% | +131.70% | |
| 20 | Dimensional Fund AdvisorsDimensional | $58.5M | 1.25% | +6.36% | |
| 21 | Spruce Street CapitalSpruce Street Capital | $55.8M | 1.19% | 0.00% | |
| 22 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $54.1M | 1.16% | new | |
| 23 | Baker Bros. AdvisorsBaker Bros. | $52.9M | 1.13% | +143.66% | |
| 24 | Bank of AmericaBank of America | $50.4M | 1.08% | +39.09% | |
| 25 | MPM Oncology Impact ManagementMPM Oncology Impact | $45.2M | 0.97% | +2.38% |
259 managers report $4.7B of Relay Therapeutics on form 13F for the quarter ended Jun 30 '26. 29 of them hold 80% of it; SB Investment Advisers (uk) is largest at 11.17%.
Expected move
Inputsspot 18.35exp Nov 20ATM strike 18ATM straddle 2.72IV 78%